Symptoms, bothersomeness and quality of life in patients with LUTS suggestive of BPH

被引:50
作者
Bertaccini, A
Vassallo, F
Martino, F
Luzzi, L
Rossetti, SR
Di Silverio, F
Comunale, L
机构
[1] Univ Bologna, Policlin S Orsola Malpighi, Urol Clin, I-40138 Bologna, Italy
[2] Azienda Osped S Carlo, Potenza, Italy
[3] Arcispedale S Maria Nuova, Reggio Emilia, Italy
[4] Azienda Osped Civile S Maria di Terni, Rome, Italy
[5] Osped Molinette, Turin, Italy
[6] Policlin Umberto 1, Rome, Italy
[7] Osped Borgo Trento, Verona, Italy
关键词
epidemiology; benign prostatic hyperplasia; lower urinary tract symptoms; IPSS; ICS-BPH; quality of life;
D O I
10.1159/000049872
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The QUIBUS study is the largest investigation ever performed in Italy with an extensive use of the ICS-BPH questionnaire. The internal consistency of each of its three domains was high for ICS-Male (Cronbach's alpha = 0.83 and 0.89 for symptoms and bother, respectively) and lower for ICS-Sex (Cronbach's alpha = 0.63 and 0.75, see a following paper of this issue) and ICS-QoL (Cronbach's alpha = 0.53), as previously reported in the validation study of this tool. Voiding symptoms were more frequently reported, with reduced urinary stream, terminal dribble and incomplete bladder emptying as the most frequently represented. The first storage symptom in the ranking by frequency was 'rush to toilet' (70% of the population), in 7th position; however, the relevant bother was among the highest reported. Items related to urinary incontinence appeared, when present, highly bothersome (87-92% of patients), even though exhibited by a minority of the population (5-34%). The mean (+/- SD) IPSS, calculated on 970 patients, was 15 (+/- 7). Two major discrepancies were found in the comparison between IPSS and ICS-Male. First, terminal dribble, which is not considered in the IPSS, is often reported in the ICS-Male. Second, some storage symptoms (nocturia and day-time frequency) are less frequently reported in the ICS-Male than in the IPSS, while being, in general, highly bothersome. As regards QoL, 95% of subjects declared that they would not be completely happy to spend the rest of their life with their actual symptoms (ICS-QoL item 33) and 79% that BPH influences their life from 'a little' to 'a lot' (ICS-QoL item 30). The mean ( SD) IPSS-QoL single question score was 3.0 +/- 1.4 (n = 970), and the frequency distribution of scores was equivalent to the one detected by the corresponding question of ICS-QoL (item 33). SF-36, a disease-independent questionnaire about QoL, after a 1-year follow-up is expected to clarify which among the IPSS and ICS-BPH items better describe the impact of BPH on QoL. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:13 / 18
页数:6
相关论文
共 9 条
[1]  
Abrams P, 1997, NEUROUROL URODYNAM, V16, P79
[2]   THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
FOWLER, FJ ;
OLEARY, MP ;
BRUSKEWITZ, RC ;
HOLTGREWE, HL ;
MEBUST, WK ;
COCKETT, ATK ;
BLAIVAS, JG ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1992, 148 (05) :1549-1557
[3]   Decrease in mortality from benign prostatic hyperplasia: A major unheralded health triumph [J].
Boyle, P ;
Maisonneuve, P ;
Steg, A .
JOURNAL OF UROLOGY, 1996, 155 (01) :176-180
[4]   The ICS-'BPH' study: The psychometric validity and reliability of the ICSmale questionnaire [J].
Donovan, JL ;
Abrams, P ;
Peters, TJ ;
Kay, HE ;
Reynard, J ;
Chapple, C ;
DeLaRosette, JJMCH ;
Kondo, A .
BRITISH JOURNAL OF UROLOGY, 1996, 77 (04) :554-562
[5]   Using the ICSQoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study [J].
Donovan, JL ;
Kay, HE ;
Peters, TJ ;
Abrams, P ;
Coast, J ;
MatosFerreira, A ;
Rentzhog, L ;
Bosch, JLHR ;
Nordling, J ;
Gajewski, JB ;
Barbalias, G ;
Schick, E ;
Silva, MM ;
Nissenkorn, I ;
DelaRosette, JJMCH .
BRITISH JOURNAL OF UROLOGY, 1997, 80 (05) :712-721
[6]   URINARY SYMPTOMS IN THE COMMUNITY - HOW BOTHERSOME ARE THEY [J].
JOLLEYS, JV ;
DONOVAN, JL ;
NANCHAHAL, K ;
PETERS, TJ ;
ABRAMS, P .
BRITISH JOURNAL OF UROLOGY, 1994, 74 (05) :551-555
[7]   Impact of drug therapy on benign prostatic hyperplasia-specific quality of life [J].
Rhodes, PR ;
Krogh, RH ;
Bruskewitz, RC .
UROLOGY, 1999, 53 (06) :1090-1098
[8]   Relief of BPO or improvement in quality of life? [J].
Teillac, P .
EUROPEAN UROLOGY, 1998, 34 :3-9
[9]   The international continence society ''benign prostatic hyperplasia'' study: International differences in lower urinary tract symptoms and related bother [J].
Witjes, WPJ ;
DeLaRosette, JJMCH ;
Donovan, JL ;
Peters, TJ ;
Abrams, P ;
Kay, HE ;
Hofner, K ;
Kinn, AC ;
Walter, S .
JOURNAL OF UROLOGY, 1997, 157 (04) :1295-1300